IFFAT HASHMI: Open Payments
NPI 1275391377 · WETHERSFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,478 in 65 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $279 · 2025 $1,478
Food & beverage: $1,478
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $234 |
| GlaxoSmithKline, LLC. | 10 | $233 |
| Novo Nordisk Inc | 9 | $196 |
| AstraZeneca Pharmaceuticals LP | 8 | $141 |
| Actelion Pharmaceuticals US, Inc. | 3 | $88 |
| Exact Sciences Corporation | 3 | $78 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Amneal Pharmaceuticals LLC | 3 | $66 |
| Amgen Inc. | 3 | $63 |
| Abbott Laboratories | 2 | $47 |
Products named: TRELEGY ELLIPTA, MOUNJARO, BREZTRI, OPSUMIT, Cologuard Collection Kit, TRINTELLIX, UNITHROID, Ozempic.
Industry payments across CT — which companies pay providers there.
